These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34215396)

  • 21. Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases.
    Jain S; Nehra M; Kumar R; Dilbaghi N; Hu T; Kumar S; Kaushik A; Li CZ
    Biosens Bioelectron; 2021 May; 179():113074. PubMed ID: 33596516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mosquito-transmitted infections].
    Jelinek T
    Internist (Berl); 2018 Jan; 59(1):57-73. PubMed ID: 29270717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the sick returned traveler.
    Wu HM
    Semin Diagn Pathol; 2019 May; 36(3):197-202. PubMed ID: 31072653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arboviral diseases and malaria in Australia, 2013-14: Annual report of the National Arbovirus and Malaria Advisory Committee.
    Knope KE; Muller M; Kurucz N; Doggett SL; Feldman R; Johansen CA; Hobby M; Bennett S; Lynch S; Sly A; Currie BJ;
    Commun Dis Intell Q Rep; 2016 Sep; 40(3):E400-E436. PubMed ID: 28278416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidemiology and neurological complications of infection by the Zika virus: a new emerging neurotropic virus.
    Carod-Artal FJ
    Rev Neurol; 2016 Apr; 62(7):317-28. PubMed ID: 26988170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the traveler in emerging infections and magnitude of travel.
    Chen LH; Wilson ME
    Med Clin North Am; 2008 Nov; 92(6):1409-32, xi. PubMed ID: 19061759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States: A Review of Measles and Pertussis.
    Phadke VK; Bednarczyk RA; Salmon DA; Omer SB
    JAMA; 2016 Mar; 315(11):1149-58. PubMed ID: 26978210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Travel-Related Diagnoses Among U.S. Nonmigrant Travelers or Migrants Presenting to U.S. GeoSentinel Sites - GeoSentinel Network, 2012-2021.
    Brown AB; Miller C; Hamer DH; Kozarsky P; Libman M; Huits R; Rizwan A; Emetulu H; Waggoner J; Chen LH; Leung DT; Bourque D; Connor BA; Licitra C; Angelo KM
    MMWR Surveill Summ; 2023 Jun; 72(7):1-22. PubMed ID: 37368820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The re-emergency and persistence of vaccine preventable diseases.
    Borba RC; Vidal VM; Moreira LO
    An Acad Bras Cienc; 2015 Aug; 87(2 Suppl):1311-22. PubMed ID: 26312431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Emerging and Re-emerging Virus Infections in Japan: Dengue Fever, Zika Virus Disease, and SFTS].
    Saijo M
    Yakugaku Zasshi; 2020; 140(7):895-899. PubMed ID: 32612052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases.
    Weaver SC; Charlier C; Vasilakis N; Lecuit M
    Annu Rev Med; 2018 Jan; 69():395-408. PubMed ID: 28846489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccine development for emerging virulent infectious diseases.
    Maslow JN
    Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid response to an emerging infectious disease - Lessons learned from development of a synthetic DNA vaccine targeting Zika virus.
    Kudchodkar SB; Choi H; Reuschel EL; Esquivel R; Jin-Ah Kwon J; Jeong M; Maslow JN; Reed CC; White S; Kim JJ; Kobinger GP; Tebas P; Weiner DB; Muthumani K
    Microbes Infect; 2018 Dec; 20(11-12):676-684. PubMed ID: 29555345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ocular manifestations of emerging arboviruses: Dengue fever, Chikungunya, Zika virus, West Nile virus, and yellow fever.
    Merle H; Donnio A; Jean-Charles A; Guyomarch J; Hage R; Najioullah F; Césaire R; Cabié A
    J Fr Ophtalmol; 2018 Jun; 41(6):e235-e243. PubMed ID: 29929827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ocular manifestations of emerging arboviruses: Dengue fever, Chikungunya, Zika virus, West Nile virus, and yellow fever (French translation of the article)].
    Merle H; Donnio A; Jean-Charles A; Guyomarch J; Hage R; Najioullah F; Césaire R; Cabié A
    J Fr Ophtalmol; 2018 Sep; 41(7):659-668. PubMed ID: 30173871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Applying lessons of COVID-19 and other emerging infectious diseases to future outbreaks.
    Bloch EM; Sullivan DJ; Casadevall A; Shoham S; Tobian AAR; Gebo K
    mBio; 2024 Jun; 15(6):e0110924. PubMed ID: 38780294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deadly viral syndrome mimics.
    Lowenstein R
    Emerg Med Clin North Am; 2004 Nov; 22(4):1051-65, ix-x. PubMed ID: 15474781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ebola, Dengue, Chikungunya, and Zika Infections in Neonates and Infants.
    de St Maurice A; Ervin E; Chu A
    Clin Perinatol; 2021 Jun; 48(2):311-329. PubMed ID: 34030816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Viral Emerging Diseases: Challenges in Developing Vaccination Strategies.
    Trovato M; Sartorius R; D'Apice L; Manco R; De Berardinis P
    Front Immunol; 2020; 11():2130. PubMed ID: 33013898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.